Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples